Catheter Ablation for Ventricular Tachycardia in Patients With Desmoplakin Cardiomyopathy

JACC Clin Electrophysiol

16 February Feb 2024 2 months ago
  • Tondo C.

Desmoplakin (DSP) pathogenic/likely pathogenic (P/LP) variants are associated with malignant phenotypes of arrhythmogenic cardiomyopathy (DSP-ACM). Reports of outcomes after ventricular tachycardia (VT) ablation in DSP-ACM are scarce.

Reference: Catheter Ablation for Ventricular Tachycardia in Patients With Desmoplakin Cardiomyopathy.
Gasperetti A, Peretto G, Muller SA, Hasegawa K, Compagnucci P, Casella M, Murray B, Tichnell C, Carrick RT, Cadrin-Tourigny J, Schiavone M, James C, Amin AS, Saguner AM, Dello Russo A, Tondo C, Stevenson W, Della Bella P, Calkins H, Tandri H. JACC Clin Electrophysiol. 2023 Dec 14:S2405-500X(23)00897-6.

Go to PubMed